Trials / Completed
CompletedNCT06032468
ARC Intellicare for Telerehabilitation
ARC Intellicare for Telerehabilitation in Neurological Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
In the last 5 years, the available literature evidence has indicated that, in terms of clinical efficacy, telerehabilitation can give comparable results compared to face-to-face rehabilitation. Studies of post-stroke patients have revealed some benefits of telerehabilitation, such as the ability for patients to self-record pain, mood and activity. Telerehabilitation has comparable efficacy to face-to-face rehabilitation for the recovery of some abilities, such as motor function, Activities of Daily Living (ADL), and independence; it is less effective, however, for the recovery of balance control. Published reviews concerning, in particular, neurological/neurodegenerative diseases show that telerehabilitation systems are effective in maintaining and/or improving some motor aspects, such as balance and gait, and non-motor aspects, such as mood and quality of life; they also increase patient satisfaction, so in the long term they appear to be beneficial, convenient and satisfying for patients and operators. ARC Intellicare is a device undergoing certification as a Class I Medical Device (DM), already clinically tested during two uncontrolled clinical feasibility studies: ARCANGEL study (post-stroke, ClinicalTrials.gov Identifier: NCT03787433) and RICOMINCIARE study (post-COVID19 and Parkinson's disease, ClinicalTrials.gov Identifier: NCT05074771).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ARC Intellicare | wearable devices to guide rehabilitation exercise |
| OTHER | Rehabilitation sheets | rehabilitation exercise sheets to guide rehabilitation exercise |
Timeline
- Start date
- 2023-01-09
- Primary completion
- 2023-09-30
- Completion
- 2023-12-31
- First posted
- 2023-09-13
- Last updated
- 2024-03-13
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06032468. Inclusion in this directory is not an endorsement.